HC Berlin Pharma AG
HC Berlin Pharma AG appoints new members in the Advisory Board
HC Berlin Pharma AG / Change of Personnel Release of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer / publisher is solely responsible for the content of this announcement. ---------------------------------------------------------------------- Berlin, February 5, 2009 - HC Berlin Pharma AG, a company listed on the Open Market of the Frankfurt Stock Exchange, announces that Peter Jooste and Prof. Dr. Siegfried G. Schoppe were appointed as new members in the Advisory Board of the organization on January 1, 2009. The members of the Advisory Board are personalities from economy, science and pharmacy significantly involved in fundamental decisions and questions of strategy assisting HC Berlin Pharma AG with advisory capacity. Peter Jooste is already closely connected as a chairman of the board of the Australian Eastland Medical Systems Ltd and well-known as respectable author and Queens Councel (QC) in tight cooperation with the Berlin company. Eastland Medical Systems Ltd holds shares in HC Berlin Pharma AG. Siegfried G. Schoppe brings with him substantial competence as well as a wide network in the areas of Economy and Finances as a Professor of the University of Hamburg, as a dean of the Euro-Business-College and as Chairman of Allfinanz Academy AG. 'With Peter Jooste and Siegfried G. Schoppe we have won two members with outstanding international economic knowledge and worldwide contacts. This know-how and the far-reaching network were vital for the appointment to the Advisory Board', explains Rudolf W. Schötteldreier, Chairman of the Board of the HC Berlin Pharma AG, welcoming the new members. Further information on HC Berlin Pharma AG please see www.hcberlinpharma.ag. For detailed information please contact directly our Investor Relations Team: esVedra consulting GmbH t: +49. 89. 28 80 81 33 f: +49. 89. 28 80 81 49 info@esvedra-consulting.com www.esvedra-consulting.com About HC Berlin Pharma AG HC Berlin Pharma AG is a pharmaceutical company listed on the Open Market of the Frankfurt Stock Exchange, which develops and will manufacture pharmaceutical and medical technology solutions at its headquarter in Berlin. The company founded in May 2007 is developing new pharmaceutical forms of already tried and tested substances which guarantee higher efficiency and healing capacity. The flagship product of HC Berlin Pharma AG is ArTiMist™, a sublingual spray for malaria treatment, especially designed for infants and children. NiCoSorb™, a nicotine replacement therapy is another aerosol spray offered by HC Berlin Pharma AG. In the field of medical technology HC Berlin Pharma AG offers safe injection syringes, ClipOn™ and VetLok™, for human and veterinary medicine. HC Berlin Pharma AG has also specialized in the production of tamper evident and childproof packaging for remedies. Disclaimer This release only serves general purposes and is by no means intended as an invitation to buy or sell shares of HC Berlin Pharma AG. 05.02.2009 Financial News transmitted by DGAP ----------------------------------------------------------------------
Latest News
Latest Reports
No Reports found
Upcoming Events
No Events found
Webcasts
No Webcasts found